Bart Walker Partner

Save current page as PDF

Bart Walker, Co-chair of the Healthcare & Life Sciences Industry Team, focuses almost exclusively on healthcare mergers and acquisitions, strategic joint ventures and healthcare regulatory advice. His practice includes advising healthcare providers as well as equity sponsors and lenders to the healthcare services sector. In connection with representing healthcare providers, he works with hospitals, ambulatory surgery centers, dental services organizations (DSOs), urgent care providers, large physician group practices, and other ancillary services providers on their most important regulatory and transactional matters.

He regularly represents private equity funds, healthcare company founders, sellers, physicians, and other capital providers in various healthcare-related purchase, sale, and financing transactions. He has assisted in the re-syndication and start-up of numerous ambulatory surgery centers and hospital-physician joint ventures. He regularly lectures and writes on transactional and regulatory issues affecting a wide range of healthcare businesses.

While earning his law degree from the University of Notre Dame, Bart was named a White Scholar of the Thomas J. White Center on Law and Government. As an undergraduate, he was named a Morehead Scholar at the University of North Carolina at Chapel Hill.

“…incredibly responsive … Bart’s knowledge and experience in the health care space ranging from representing healthcare systems, providers and private equity firms brings a unique value and perspective. He also is able to maintain calm in very contentious negotiations…” – Legal 500, 2022

“… Approachable, willingness to develop solutions to meet the needs of clients, and supports associates to demonstrate their individual skills/expertise without grandstanding.” – Legal 500, 2022


  • Representation of a private equity fund in the multi-million dollar acquisition of an administrative services provider to a multi-site ophthalmology practice in New York.
  • Represented multiple tax-exempt health systems in connection with
    affiliation and sale transactions.
  • Represented large dermatology practice in formation of physician management
    services organization with private equity sponsor.
  • Represented private equity-backed dental services organization in
    multi-practice roll up.
  • Represented dental services organization in connection with initial formation
    and structuring, including establishment of dental practice and de novo clinical
  • Represented nationwide clinical pathology lab business in growth recapitalization transaction with private equity fund.
  • Represented strategic acquirer in acquisition of majority interest in ambulatory surgery center.
  • Represented physician-owned ambulatory surgery center in sale to national strategic acquirer.
  • Negotiated tri-party joint venture surgery center among major health system, management company, and physician members.
  • Negotiated de novo surgery center joint venture between large hospital system and major orthopedic physician practice.
  • Represented a private equity fund in diligence and acquisition of one of the largest ASC chains in the country.
  • Represented a private equity fund in the acquisition of a multisite durable medical equipment provider.
  • Conducted regulatory and compliance diligence and transaction services on the acquisition of a medical device and pharmaceutical distributor, including change of ownership issues in 40 states.
  • Advised hospital on compliance with Stark, anti-kickback, and tax-exempt laws in the development of compensation arrangements for various physician services.
  • Represented nationwide provider of dialysis services in multi-facility dialysis facility acquisition.
  • Represented lead agent in healthcare regulatory aspects of syndicated credit facility to national provider of healthcare services.
  • Advised parties in structuring off-campus, provider-based facility.